Maibeth is a founding Shareholder at Maynard Cooper and member of the Product Liability, Banking Litigation and Appellate & Post-Verdict practices.
Maibeth’s practice focuses on banking, insurance, and other commercial litigation, as well as drug and medical device litigation, including cases involving diet drugs, phenylpropanolamine, thimerosal-containing vaccines, hormone replacement therapy, rheumatoid arthritis therapies, contraceptive devices, breast implants, dialyzers, anti-reflux devices, latex gloves, incubators, and component parts of oxygen delivery systems. The evaluation of clinical trials is critical to the successful litigation of drug and medical device cases.
Her litigation skills and talents have earned her recognition as a Leading Litigator by Chambers USA: America's Leading Lawyers for Business. Her list of recognition also includes several distinctions by Super Lawyers and Best Lawyers®, among which are Alabama Super Lawyers "Top 10 Lawyers," "Top 25 Women Lawyers," and in 2016, as Mid-South Super Lawyers "Top 50 Female Lawyers." She has been tapped three times as a Best Lawyers® "Lawyer of the Year" in the Birmingham region. Maibeth also holds an AV-Preeminent Rating by Martindale-Hubbell.
She received her J.D. from Vanderbilt University School of Law and holds a B.A., summa cum laude, from the University of the South (Sewanee).